Lymphopenia during chemoradiation—foe or friend

BACKGROUND: Severe lymphopenia during treatment is considered to be a poor prognostic factor. The current literature lacks information regarding its impact on various outcomes in locally advanced head-and-neck cancer patients in a prospective setting. METHODS: We recently published a randomised stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Vijay M, Singh, Gunjesh Kumar, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Satam, Kavita Nawale, Mukadam, Sadaf Abdulazeez, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581337/
https://www.ncbi.nlm.nih.gov/pubmed/33144877
http://dx.doi.org/10.3332/ecancer.2020.1109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581337/
https://www.ncbi.nlm.nih.gov/pubmed/33144877
http://dx.doi.org/10.3332/ecancer.2020.1109

Ejemplares similares